The Middle EAST Epigenetic Antibodies Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by several factors, including the rising prevalence of diseases linked to epigenetic modifications, increasing research funding, and advancements in biotechnology. The demand for epigenetic...